---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-020735"
form_type: "8-K"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T03:35:39.839181+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# MyMD Pharmaceuticals sets 2023 annual meeting for July 31, record date June 21, proposal deadline June 19

## Summary
- Annual Meeting to be held virtually on July 31, 2023.
- Record date for voting is June 21, 2023.
- Deadline for stockholder proposals under Rule 14a-8 is June 19, 2023.
- Director nominations and universal proxy notices also due by June 19, 2023.
- Meeting date changed by more than 30 days from 2022 anniversary.

## SEC filing metadata
- accession: 0001493152-23-020735
- form_type: 8-K
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000149315223020735/0001493152-23-020735-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000149315223020735/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-020735
- JSON: https://secwatch.observer/filing/0001493152-23-020735.json
- Plain text: https://secwatch.observer/filing/0001493152-23-020735.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.